Fundraising Fox

Aikium

Founded 2022 · 7 employees on LinkedIn · 2 known investors

Aikium combines deep learning with large-scale wet-lab experimentation to design and screen protein libraries, aiming to develop protein therapeutics for hard-to-treat targets such as GPCRs and ion channels. The company focuses on drug discovery for parts of the human proteome that conventional antibodies and small molecules cannot address.

Founders & leadership

Aikium was founded in 2022 by Eswar I, Shankar Shastry, and Venkatesh Mysore.

EI
Eswar IFounder
SS
Shankar ShastryFounder
VM
Venkatesh MysoreFounder
DE
Dr. Eswar IyerCEO | Head of Synthetic Biology
MTMichael Tolentino
Michael TolentinoinChief Development Officer
DS
Dr. Shankar ShastryVice President | Head of Protein Sciences

Investors · 2

Competitors · 4

by search overlap

Companies competing with Aikium for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Aikium do?
Aikium combines deep learning with large-scale wet-lab experimentation to design and screen protein libraries, aiming to develop protein therapeutics for hard-to-treat targets such as GPCRs and ion channels. The company focuses on drug discovery for parts of the human proteome that conventional antibodies and small molecules cannot address.
Who founded Aikium?
Aikium was founded by Eswar I, Shankar Shastry, Venkatesh Mysore in 2022.
Who are Aikium's investors?
Aikium's investors include Bantam Group, Civilization Ventures Management, Llc.